Bill Taranto - President, GHI Fund, Merck - Corporate Venturing For Integrated Healthcare Solutions

Bill Taranto is President of the Global Health Innovation Fund at Merck (https://www.merckghifund.com/taranto.html) and founding partner since inception in 2010.

Merck Global Health Innovation Fund (Merck GHI) is a corporate venture capital group utilizing a healthcare ecosystem strategy, investing globally in platform companies with proven technologies or business models where Merck's expertise can accelerate revenue growth and enhance value creation to ultimately develop integrated healthcare solutions.

Merck GHI has $500M under management per an evergreen model and invests broadly in the domain of digital health, and other segments, and has made over 60 investments in portfolio companies, and has over 20 exits. They invest across the segments of Therapy Planning, Care Management, Health Analytics & AI, eClinical Trials and enabling technologies.

Bill has more than 30 years of health care experience including over 20 years of healthcare investing.

In addition to his experience in venture investing, Bill has more than a decade of management operations experience.

Bill is also the chairman of the Merck Innovative Ventures Board, a group that manages the identification and funding of portfolio businesses; and is also Chairman of the GHI Fund LLC Management Board.

Prior to joining Merck, Bill spent 18 years at Johnson & Johnson in various venture capital, marketing, sales and business development roles. Before J&J, Bill spent eight years in investment banking. He has a Bachelor of Business Administration from St. Bonaventure University.